FeatureName:residual_tumor|Type:CAT|StatisticMethod:kruskal|GroupComparison:r0/r2/rx/r1|Statistics:   8.342296|Direction: 1|PValue:3.94426e-02|FDR:0.238370772;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:   9.065860|Direction: 1|PValue:2.84279e-02|FDR:0.176058270;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   7.948740|Direction: 1|PValue:1.87911e-02|FDR:0.083981919;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 647.000000|Direction: 1|PValue:1.76237e-02|FDR:0.061928006;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.257030|Direction:-1|PValue:2.92897e-02|FDR:0.092528950;FeatureName:LRP1B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 665.000000|Direction: 1|PValue:4.71941e-02|FDR:0.421679049;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 665.000000|Direction:-1|PValue:3.63693e-02|FDR:0.135430167;FeatureName:APC_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 920.000000|Direction: 1|PValue:2.30487e-02|FDR:0.328885476;FeatureName:COL6A3_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 534.000000|Direction: 1|PValue:3.06242e-02|FDR:0.398136736;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:1141.000000|Direction: 1|PValue:3.12501e-02|FDR:0.373721149;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 839.000000|Direction: 1|PValue:2.56800e-02|FDR:0.104985726;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 677.000000|Direction: 1|PValue:3.34424e-02|FDR:0.202108423;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.400002|Direction: 1|PValue:1.12831e-04|FDR:0.000712885;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.375537|Direction: 1|PValue:3.11694e-04|FDR:0.001883715;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.360400|Direction: 1|PValue:5.62271e-04|FDR:0.003005988;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.404941|Direction: 1|PValue:9.10114e-05|FDR:0.000973122;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.213672|Direction: 1|PValue:4.56176e-02|FDR:0.253633947;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.347570|Direction: 1|PValue:9.06770e-04|FDR:0.007373054;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.218290|Direction:-1|PValue:4.10352e-02|FDR:0.146253835;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.377964|Direction:-1|PValue:2.82798e-04|FDR:0.002456807;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.261588|Direction:-1|PValue:1.38222e-02|FDR:0.174662578;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.425972|Direction:-1|PValue:3.50720e-05|FDR:0.000443182;FeatureName:17p12_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.230983|Direction:-1|PValue:3.03725e-02|FDR:0.136186334;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.359249|Direction:-1|PValue:5.87388e-04|FDR:0.004499328